Although assessment of asthma control is important to guide treatment, it is diffi cult since the temporal pattern and risk of exacerbations are often unpredictable. In this Review, we summarise the classic methods to assess control with unidimensional and multidimensional approaches. Next, we show how ideas from the science of complexity can explain the seemingly unpredictable nature of bronchial asthma and emphysema, with implications for chronic obstructive pulmonary disease. We show that fl uctuation analysis, a method used in statistical physics, can be used to gain insight into asthma as a dynamic disease of the respiratory system, viewed as a set of interacting subsystems (eg, infl ammatory, immunological, and mechanical). The basis of the fl uctuation analysis methods is the quantifi cation of the long-term temporal history of lung function parameters. We summarise how this analysis can be used to assess the risk of future asthma episodes, with implications for asthma severity and control both in children and adults.
Introduction
Bronchial asthma and chronic obstructive pulmonary disease (COPD) are the two most common chronic respiratory diseases, aff ecting millions of children and adults. Nevertheless, many features of these diseases, including pathogenesis and progression are not fully understood. To treat patients with asthma or COPD correctly, markers of disease severity and control 1 are needed that can be used to predict future exacerbations. 2 However, in bronchial asthma the association between stimuli and exacerbations is poor [3] [4] [5] and increasing evidence suggests that the classic paradigm of asthma, sequentially linking the trigger to the symptoms (fi gure 1), is incomplete in many situations. Indeed, the association between trigger and infl ammation, 6,7 infl ammation and bronchial hyper-reactivity, [8] [9] [10] [11] [12] and airway obstruction and symptoms is not always strong. Asthma phenotypes are very heterogeneous-eg, infl ammation can be predominantly eosinophilic, neutrophilic, or involve other pathways. [13] [14] [15] [16] [17] [18] [19] Many infl ammatory pathways that are part of the asthmatic cascade operate within a complex web of interactions, including various subsystems that are part of the host defence, immunity, and infl ammation, and lung mechanics. Although COPD is diff erent, the distinction between it and asthma is beginning to blur. 20, 21 Additional interactions can occur between the organism and the environment, with several external heterogeneous triggers (eg, viral infections, allergens, and pollutants), showing high temporal variability.
Assessment of asthma severity and control based on one clinical marker, such as the averaged set of symptoms, has limitations because of the complexity of the disease. A multidimensional approach with more than one parameter or including statistical measures of parameters with time should provide a more com prehensive picture of the disease process. In this Review, we will explain the unpredictable nature of clinical events and exacerbations based on the complex and non-linear behaviour of the respiratory system fl uctuating with time. Specifi cally, we will discuss how the network structure of the airway tree and the lung tissue contributes to unexpected sudden disease exacerbations in both asthma and emphysema. With fl uctuation analysis of the history of physiological parameters, we show how prediction of exacerbations and hence treatment strategies might be improved.
Classic method of assessment of asthma control and severity
Asthma severity can be considered as the intrinsic intensity of the disease and is measured most easily and directly when a patient is not under long-term control treatment. Asthma control is the degree to which the manifestations of the disease (ie, symptoms, functional impairments, and risk of exacerbations) are minimised by treatment. Disease severity and control form the basis of asthma treatment according to the global strategy for asthma management and prevention guidelines, 1, 22 and both include the present impairment and future risks. Assessment of the present impairment is easier and related to the frequency and intensity of symptoms, including impairment of quality of life (night-time awakenings, need for short-acting β 2 agonists for quick relief of symptoms, work or school days missed, and ability to engage in normal daily activities) and functional limitation. However, evidence suggests that individual perceptions of symptoms or severe exacerbation vary among patients, and that diffi culties in the perception of body sensations and expression of emotions 23 are more frequently associated with severe asthma and near fatal asthma. These diffi culties suggest that additional objective parameters for the description of asthma severity are needed. The preferred method for objective assessment of functional limitation is to characterise lung function with spirometry, including indices such as forced expiratory volume in 1 s (FEV 1 ), forced vital capacity (FVC), and the FEV 1 /FVC ratio. Spirometry is widely used to defi ne severity in adults.
1 Most school children have normal FEV 1 values irrespective of their asthma severity as defi ned on the basis of symptoms. [24] [25] [26] In children, the FEV 1 /FVC ratio seems to be better associated with asthma severity than in adults. 24, 25 Although peak expiratory fl ow (PEF) is not reliable for the assessment of the severity of airway obstruction, 27, 28 studies in adults have shown that it can be a useful method to monitor trends and quantify the history of asthma control.
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Risk assessment and prediction of exacerbations
The risk or likelihood of asthma exacerbations is diffi cult to predict, and disease severity and risk of exacerbations are not always closely associated, 30 because some patients who have few symptoms or impairment of quality of life might still be at serious risk of severe, even life-threatening, exacerbations. 31 Many studies have tried to identify clinical risk factors that predict severe airway obstruction or re-admission rates on a short-term basis.
2,13,32-47 Evidence suggests that frequent asthma symptoms, repeated hospital admissions or emergency visits in the past, frequent use of inhaled short-acting β 2 agonists, present use of systemic corticosteroids, or recent withdrawal from systemic corticosteroids are risk factors for future asthma exacerbation, admission, or even death.
Very few studies have addressed the issue of lung function as a predictor of admission or asthma exacerbation in the short term. Low values of FEV 1 and maximum mid-expiratory fl ow have been proven to predict subsequent asthma episodes in longitudinal trials in adults 48 and children, [49] [50] [51] respectively. The predictive value of bronchial hyper-reactivity for asthma relapse during stepwise reduction of inhaled corticosteroids was reported in studies. 52, 53 Such data are consistent with the results of Sont and coworkers, 54 who showed improved asthma control if bronchial reactivity tests were used to guide asthma treatment. PEF monitoring reduces unscheduled doctors' visits in adults, 55 and PEF variation after bronchodilator response has been proven to be related to admission rates in adults and children. 44, 56, 57 However, lung function deterioration and exacerbation risks are not always closely associated in children; Fuhlbrigge and colleagues 51 reported that even children who had normal values of lung function had exacer bations.
The assessment of comorbidities, environmental risk factors, and many biomarkers-such as blood or sputum eosinophils, eosinophilic cationic protein, fractional exhaled nitric oxide concentration, serum immunoglobulin E, number of positive skin tests, pH, infl ammatory mediators, or various metabolites in exhaled breath condensates-have been proposed as potential markers of the asthma exacerbation risk in adults and children. 58 Some of these markers, such as fractional exhaled nitric oxide concentration, might contribute to a better defi nition of the eosinophilic asthma phenotype by contrast with viral wheezing disorders of early childhood, and could be useful for the prediction of the exacerbation risk in individual patients. 4 , 19, 52, 53, [59] [60] [61] [62] [63] [64] [65] The updated global strategy for asthma management and prevention guidelines 1 have placed the emphasis for treatment of asthma mainly on control. However, both severity and control include the present impairment and future risks. The association between severity and control is multidimensional, highly complex, and varies with time. Assessment of a patient's asthma control alone might result in the loss of important information. We postulate that new methods that can account for the complex time-varying interaction between severity and control could provide improved insight into the disease process in the future.
Multidimensional approaches
In practice, clinicians implicitly use a probabilistic approach 66 to monitor and treat their patients. Clinicians see the asthmatic lung as a complex web of interacting components, and they are used to integrating probabilistic knowledge about various clinical tests and biomarkers to make informed decisions about treatment. We believe that clinical experience is invaluable for the treatment of complex diseases with several interacting components. In clinical science, this approach has been adapted with the design of multidimensional asthma severity assessment strategies. 22, 67 Standardised question naires like the asthma control test, 68 childhood asthma control test, 69 asthma control questionnaire, 70 asthma therapy assessment questionnaire control index, 71, 72 global initiative for asthma, 22 and the national asthma education and prevention programme 73 have been developed to help with the assessment of disease severity and to guide control. In such tests, clinical symptoms, activity limitation, rescue medication, lung function, and self-perception of control are assessed in varying combinations. Although physicians are able to identify lung abnormality as obstructive, 74 clinical assessment of the degree of airfl ow obstruction 75 or prediction of whether the obstruction is reversible is diffi cult 74, 76 because pulmonary function measures do not always correlate with symptoms. In a study, a third of children with moderate to severe asthma were reclassifi ed to a more severe category when FEV 1 was considered in addition to symptom frequency. 77 Conversely, most children in another study who had mild-to-moderate asthma classifi ed by symptoms had normal FEV 1 . 24 Infl ammatory markers, such as fractional exhaled nitric oxide concentration, have been used instead of symptoms to monitor disease control. 4, 52, 53, 59, 78 New multidimensional methods to characterise and moni tor the complexity of asthma have been proposed for use in clinical disease; these methods include gene-expression profi les (genomics and proteomics 79 ), volatile organic compounds, 80 or mixtures of metabolites in exhaled breath condensates (eg, metabolomics 81 ). Some of these new methods use a novel probabilistic approach, and have the potential to provide a comprehen sive understanding of diff erent asthma phenotypes and disease activity that is based on fewer clinical assumptions.
Thus, the description of asthma is much more comprehensive with multidimensional approaches than with symptoms alone. 82 The need for these approaches is further supported by factor-analysis studies showing poor correlation between various disease markers. 83, 84 Panel: What are the key messages for the clinician?
1 The complex nature of the respiratory system The fl uctuating nature of environmental stimuli interacting non-linearly with the complex web of immunological, mechanical, and infl ammatory components of the respiratory system is responsible for the unpredictability of asthma and chronic obstructive pulmonary disease (COPD) exacerbations. However, this complexity can be characterised with appropriate statistical analysis methods.
Fractal airway network and asthma attacks
The airways in the lung form a three-dimensional, self-similar, fractal structure. In asthma and particularly in the remodelled lung, alterations in the structural properties of the airway network make the lung vulnerable to sudden avalanches of heterogeneous airway narrowing even in the absence of a large and apparent stimulus, which contributes to the unpredictable time course of asthma, including some fatal attacks.
3 Network structure of the lung parenchyma and progression of emphysema The structure of the parenchyma forms a complex three-dimensional elastic network. In the remodelled emphysematous lung, the wide distribution of mechanical forces within the alveolar wall network can lead to the rupture of elastic fi bres, possibly launching a cascade of subsequent ruptures of neighbouring alveolar walls. Such an event represents an acute exacerbation with a sudden appearance of large emphysematous lesions on lung CT images and can occur even in the absence of an apparent stimulus. Such a process might contribute to the unpredictable but relentless deterioration of lung function in emphysema.
How does a complex system approach the critical condition?
Imagine a snow fi eld in the Swiss Alps. After heavy snow fall for several days, the snow slowly builds up layer by layer. The pressure due to the weight of the snow increases in a heterogeneous manner over the terrain until the system reaches a critical condition. Compared with the size of the fi eld, a skier entering this terrain is a tiny perturbation. Yet the small weight of the skier can launch an avalanche. The snow fi eld acts somewhat similar to a network, in which the present spatial distribution of forces is a consequence of events in the past with a cumulative eff ect on the present critical condition of the network. However, when the system is perturbed, the reaction occurs suddenly with substantial redistribution forces during the cascade. The spatial progression of the cascade is similar to the catastrophic shift in an asthma attack or the sudden appearance of bulla in emphysema. The history of cascades becomes a process that is correlated during a long period, called long-range correlations. Such correlation properties contain information about the past and present conditions of the system. The knowledge of the correlations would allow us to predict future events in a probabilistic manner. To measure such long-range correlation properties, the system needs to be assessed during a long period and the correlation properties have to be extracted from the irregular fl uctuations of a given output variable (see below).
(Continues on next page)
Unpredictability of disease progression
Clinicians are well aware of the diffi culties in trying to predict the temporal fl uctuations in disease progression or prognosis even with multidimensional approaches. The assessment of the risk of future asthma exacerbations, progressive reduction in lung function, or risk of adverse eff ects from medication remains elusive, and the time course of events is often unexpected. For example, small or even undetected triggers can lead to unexpected fatal asthma attacks, 3 and even children with normal lung function can have exacerbations. 51 In patients with COPD, the frequency of acute exacerbations have been linked to a reduction in lung function with age. [85] [86] [87] Hence, the possibility exists that disease progression can occur in sudden acute steps, both in asthma and COPD. As a novel hypothesis of why this is the case, we pro pose several reasons related to the fl uctuating nature of the environ mental stimuli and their interaction with the complexity of the respiratory system (panel, key message 1).
Fluctuating and heterogeneous environmental stimuli
The respiratory system is constantly exposed to diff erent and time-varying stimuli. We often assume that the strength of the environmental stimulus is proportionally related to the resulting physiological eff ect in the airways and that this eff ect occurs instantaneously without any delay as embodied in the idea of bronchial hyper-reactivity (measured by the bronchial challenge test). However, several examples show that the eff ects can arise with lags and are dependent on the nature of stimulus. For example, Gent and colleagues 89 reported that although environ mental pollution varies widely with time and that the amount of pollution is associated with time-dependent fl uctuations in respiratory symptoms in patients with asthma, the fl uctuations in exposure and symptoms are only weakly related. Another example is provided by Vahlhvist and co-workers, 90 who showed that during the birch season, the environmental allergen concentrations fl uctuate with time, resulting in variations in fractional exhaled nitric oxide concentrations, lung function, and symptoms. Time lags between pollen stimuli and resulting infl ammatory markers might even occur. 60 However, the association between stimuli and these biomarkers is weak and inconsistent.
Similarly, exposure to fi ne particulate matter (less than 2·5 μm in diameter) has a delayed eff ect on lung function, appearing only after 3-5 days, whereas exposure to the ozone has an immediate eff ect after 1 day. 91 The existence of lag eff ects with the sustained eff ect of environmental stimuli implies information storage or memory in the respiratory system and that a cumulative eff ect can potentially be built up. Thus previous stimuli are important since each particular stimulus in the past might add to the cumulative eff ect. Other clinical examples of longlasting environ mental eff ects on the respiratory system and its immune response might be the persistent bronchial hyper-reactivity after one allergen challenge 92 or the longlasting, sustained eff ect of drug treatment for a few weeks after cessation of treatment. 93 Furthermore, the temporal pattern of environmental triggers is usually not entirely random but correlated. For example, viral triggers are associated with each other and the climate, 94 and show seasonal temporal changes similar to those of pollen. Time correlations exist for pollutants. 95 Thus, fl uctuating environmental and treatment-related stimuli interact with the highly complex respiratory system, resulting in an unpredictable temporal pattern of respiratory symptoms and lung function changes (panel, key message 1).
(Continued from previous page) 5 Long-range correlations in daily lung function parameters, and asthma severity, stability, and risk prediction Long-term fl uctuations of lung function parameters with time (months) are not random, but past and present values are inter-related such that they show weak, measurable fractal-type long-range correlations. These correlations can be fully characterised by the long-range correlation exponent α, which indicates the temporal history of the disease and, hence in the future, could be a new additional descriptor of disease severity and phenotypes, and is a predictor of future obstructive exacerbations in chronic airway diseases.
Complexity and temporal eff ects of treatment
Regularly given short-acting bronchodilator treatment can act as a series of on and off stimuli. In the presence of the unfolding eff ect of disease history with long-range correlations, such a stimulus can result in an unstable non-linear system that generates increased randomness and variability with reduced predictability. Thus, the response to β 2 agonists is related to the complex dynamic regulation of airway function in asthma. Fluctuation analysis has the potential to identify patients who might respond well or poorly to treatment with increased accuracy. Therefore, consideration of the timing eff ects of regularly given drugs on the system dynamics of a chronic disease might be necessary.
Complexity and risk prediction
For the risk prediction of future obstructive events, not only is the present value of peak expiratory fl ow is important, but also the long-range correlations embedded in many previous events and thus the history of the patient are crucial.
Asthma monitoring and risk prediction
Observation of the long-term temporal fl uctuation of one or even several (multidimensional) clinical and physiological markers and the analysis of their time correlation properties can add an additional dimension to better assess severity and design control of asthma or COPD in future monitoring and risk prediction concepts.
Complexity and importance of clinical experience
The physicists Goldenfeld and Kadanoff 88 said "As science turns to complexity, one must realize that complexity demands attitudes quite diff erent from those heretofore common in physics". We would like to add biology and medicine to the list. The experienced general practitioners would intuitively agree with this statement since it is not only necessary to know the pathophysiological mechanisms of a disease, but the clinician's personal experience with the patient's complex behaviour observed during a long period is of equal importance. The careful and quantitative assessment of the patient's history should allow an improved prediction of the patient's disease stability.
Complexity of the respiratory system
Our understanding of the pathophysiology of the respiratory system has traditionally followed a reductionist approach (fi gure 1) whereby researchers isolated and identifi ed specifi c mechanisms from the complex web of interacting subsystems. With this approach, the system is divided and studied at ever increasing resolution with the ultimate goal of reconstruction of the behaviour of the whole system. In the reductionist approach, the classic under standing of asthma is based on the notion that a trigger can induce, reactivate, or sustain airway infl am mation or bronchial hyper-reactivity, leading to airway obstruction and symptoms. Despite many fundamental advances, the reductionist approach also has many important limitations because it assumes that with knowledge of the properties of every part in isolation, the response of the entire system to any stimulus can be predicted. 96 Most biological systems are complex with a hierarchy of embedded feedback loops of subsystems (eg, immunological, infl ammatory, lung mechanics, and neurorespiratory control) that function on the basis of interactions between many components and modify environmental inputs (such as allergen exposure, infection, and air pollution), leading to fl uctuations in output or symptoms (fi gure 1). The stimulation of one component could aff ect a large number of other subsystems. Furthermore, the interaction between two subsystems is usually non-linear, which means that doubling input from one to the other does not result in a proportionate doubling of the response. Such non-linearities can even generate conditions in which several types of responses are possible. A range of external conditions and stimuli can interfere with the functioning of the subsystems. Furthermore, as clinical experience suggests, when the environmental stimulus is very strong (eg, severe viral infection), the response of the respiratory system will probably be dominated by the properties of the trigger. However, a series of weak irregular external environmental stimuli can trigger a specifi c response in a particular subsystem that might in turn propagate and potentially amplify in a non-linear cascade through other subsystems. Thus, even if all the inputs were known, which is unrealistic, the multitude of non-linear interactions and feedbacks coupled with the memory of the subsystems at diff erent time scales hinder the accurate prediction of an output variable.
Asthma is the best example of a disorder that shows complex behaviour. Comprehension of the functioning of such systems and prediction of events such as an asthma episode are not possible within the realm of the reductionist analysis. Rather, such complexity requires new considerations and a probabilistic systems approach. Although such complex behaviour can be shown in most respiratory subsystems, we discuss two specifi c examples-ie, lung function in asthma and emphysema-in which correlations dependent on the fractal and network structures of the airways and parenchyma, respectively, help explain disease progression (eg, in emphysema) and have implications for risk prediction in asthma.
Fractal airway structure: implications for sudden airway narrowing and fatal asthma
Fractals are self-similar structures in which magnifi cation of the subparts resembles the entire structure (fi gure 2). [97] [98] [99] [100] The three-dimensional structure of the airway and vascular trees are examples of distribution networks with fractal organisation. The self-similarity manifests in a branching pattern that repeats itself on several length scales. To describe their properties, the variations in a given structural feature should be measured at diff erent length scales. The way these variations depend on the length scale can then be used to characterise the entire structure with one number, the fractal dimension. Although fractality is optimum for lung growth 101 and lung ventilation, 100 it also causes some unexpected pecu liarities in diseases. 98, 102 For example, in a lung with mild ventilation in the homogeneities, bronchoconstriction and airway reopening do not take place with equal probability in every airway. Although, the distribution of ventilation in asthma is heterogeneous, 103 Venegas and col leagues 104, 105 showed with PET imaging and computer modelling that once smooth-muscle activation reaches a critical level, localised clusters of poorly ventilated lung areas can develop abruptly in discrete steps. These steps are called catastrophic shifts or avalanches, leading to new stable conditions. Because of the fractal structure of the airways with their elastic interactions through the parenchyma, small initial heterogeneities that are always present, especially in the diseased lung, can be amplifi ed, leading to sudden self-organised patches of poorly ventilated lung regions with dispersed airway closure during bronchoconstriction. An im portant implication is that an airway cannot close or open without aff ecting the neighbouring lung parenchyma and airways. Since the airways are organised into a fractal network embedded in the elastic paren chyma, the constriction of one airway can propagate and cause an avalanche-like cascade of airway constrictions in large portions of the lung. The opposite process also has important clinical implications since it is needed to relax the asthmatic airways (fi gure 3). 106 Airways in a partly collapsed lung do not open in a smooth continuous way during inhalation, but instead they do so in discrete steps. When the pressure across airway closures reaches a threshold, airway segments suddenly open, fi lling large regions with air that allows regional alveolar ventilation.
These studies provide a new way to understand the dynamics of asthma attacks. In this disease, the airways are likely to approach their local critical closing threshold pressure, which means that a small stimulus can cause a catastrophic cascade of airway closures with severe impairment of lung function. Such thresholdbased mechanisms are highly non-linear, which contributes to the poor association between the trigger and outcome in asthma. In particular, in fatal asthma the remodelled airway tree is more prone to sudden catastrophic closure and breakdown. 107 Thus, the history of symptom fl uctuations is closely related to the structural changes of the fractal airway tree combined with the irregularities of external and internal stimuli (panel, key messages 2 and 4). Although no clinical data exist, we can speculate that the airway tree has a similar role in small airway dysfunction in COPD, given the propensity of airways in COPD to collapse during forced expiratory manoeuvres.
Lung tissue network structure: implications for disease progression in emphysema
Asthma and COPD show similarities, transitions, and substantial diff erences. 20, 21, [108] [109] [110] One of the important diff erences between these two diseases is the involvement of the parenchyma. In the lung, the parenchyma forms a network of fi bres, and hence network considerations might explain the progressive nature of emphysema. One feature of emphysema, an important component of COPD, results from progressive destruction of the elastic fi bre network of the lung with time. 110, 111 High-resolution CT is a sensitive method for examination of lung structure and the changes in COPD. 112 Emphysematous regions of the lung (represented in CT as low attenuation areas) do not develop homogeneously, but in clusters of widely diff erent sizes. Mishima and colleagues 112 showed that disease progression in emphysema is consistent with the breakdown of a network of elastic springs, and Suki and colleagues 113 showed that for this process to be consistent with CT images, the breakdown of the remodelled alveolar wall network has to be governed by mechanical forces. After the failure of an elastic element, stresses are redistributed in the network, and consequently neighbouring elements can become overloaded and stop functioning, which leads to failures that occur in an avalanche-like manner. Such a process leads to a wide distribution of mechanical forces in the parenchyma, predisposing an increasing number of regions to mechanical failure. 114 This process is perhaps the fi rst physical mechanism proposed that can explain the progressive nature of emphysema. It is supported by CT imaging and by the fact that the condition of individuals with emphysema can irreversibly deteriorate following an exacerbation episode. 115 However, the question of when and where a new breakdown might arise cannot be predicted easily. Again, external triggers, such as cigarette smoke, and internal triggers, such as the subsequent infl ammation-derived enzyme activity, weaken the elastic network at random locations. Thus, disease progression is not a linear sequential process but can happen in discrete steps or as sudden deteriorations without any apparent trigger. Again, the history of exacerbations is coupled to the history of the new redistribution of structural properties in the parenchyma. Since a cascade of mechanical failures is an irreversible process that forms the microscopic basis of an acute exacerbation, at least statistically, the frequency and magnitude of such events should also correlate with deterioration in lung function. 116 Indeed, in clinical studies, exacerbation frequency aff ected the lung function and reduced the health status (panel, key message 3). [85] [86] [87] 117, 118 
Importance of history
The above avalanche-like eff ect becomes relevant when forces at the microscopic scale reach a critical threshhold so that a small stimulus can launch a cascade of events that propagate through macroscopically large portions of the system (panel, key message 4).
We postulate that in a chronic respiratory disease, stimuli that occurred in the past can still have an eff ect on the present system (fi gure 1). As described already, several clinical examples, such as delayed and cumulative eff ects of pollutants, persistent bronchial hyper-reactivity, and drug eff ects, show the eff ect of previous events (history) on the present disease state. Thus, a multitude of sustained infl ammatory, immunological, or mech anical stimuli in the past can have a longlasting cumulative eff ect on the respiratory system in health and in disease. Although separation of individual past events might not be possible, characterisation of the history might be possible with statistical techniques. Long-range correlation analysis is an example of such a technique.
Long-range correlation of lung function parameters
The extent of memory can be estimated from correlations within an output variable of the respiratory system. For instance, daily lung function tests or symptoms embody the features of the system's memory. Generally, the history of stimuli (or exposures) is not known, and can itself be a complex non-random process. However, when several inputs are coupled with immune reactions, infl ammation, neurological control, and the mechanics of breathing, the response at the whole-organism level becomes unpredictable. Nevertheless, the overall result is that the fl uctuations of the output will probably show short-term (eg, temporary airway obstruction, wheeze, and dyspnoea) and long-term (eg, persistent airway obstruction, infl ammation, and permanent remodelling) correlations. Even in the unrealistic case, when all the inputs are known and experiments are done under the most carefully controlled conditions, repeated experiments would still show variability due to, for example, the microscopic instabilities in the system related to non-linearities. To characterise these fl uctuations, use of statistical methods 106, 119, 120 that have been described for heart rate, 121, 122 fl ow rates in river networks, and information fl ow in the internet is necessary. 123 In complex systems with an underlying fractal structure, 123 the fl uctuations show correlations during long periods. These long-range correlations typically show self-similar statistical properties with several orders of time scales (fi gure 2) similar to the spatial self-similarity of fractals. Correlations can be important in risk prediction.
The usefulness of day-to-day PEF variability in the diagnosis, risk prediction, and monitoring of asthma has been discussed extensively in published work and guidelines. 22 We examined the day-to-day lung function fl uctuations in chronic asthma. 124 Individual PEF values are highly variable but not random with time (fi gure 4). We investigated the temporal pattern of PEF in 80 individuals with asthma who had taken part in a long-term clinical trial. 124, 125 In particular, we examined whether the statistical and autocorrelation properties of the time series of PEF recordings could be used to predict the risk of a future asthma episode. The fl uctuations in the twice-daily PEF measurements assessed during 6 months showed fractal-type long-range correlations. Measures of variability and correlation properties of a signal can be analysed by various methods. 126 Here we discuss the detrended fl uctuation analysis, 120, 127 which is particularly suited for quantifi cation of the correlation of the lung function history. In this analysis, the cumulative eff ect of how fl uctuations in the past aff ect fl uctuations in the present as a function of the time scale τ or how far the fl uctuations occurred in the past is quantifi ed by the fl uctuation function F. Often F follows a power function-ie, it is roughly proportional to τ α , which characterises the complex self-similar behaviour with the long-range correlation exponent α. This number is similar to the fractal dimension for spatial correlations. [128] [129] [130] [131] A value of 0·5 for α represents a random process in which one fl uctuation does not aff ect the next. A higher value of α means greater correlation with the time series, stronger deterministic characteristics, and longlasting eff ects (fi gure 4). Importantly, evidence suggests that α in the PEF series ranges between 0·6 and 0·9. Low α is associated with increased asthma severity. 124 In a temporal process, displaying long-range correlations, the magnitude of fl uctuations that occurred in the past is correlated to the present and future values. Typical of fractal processes, the eff ect of previous fl uctuations decreases slowly (according to a power law) as we look further in the past. The value of α, and hence the strength of these long-range correlations, will be aff ected by the integrated con tribution of many processes, including both external stimuli and internal mechanisms (eg, infl ammatory, immunological, remodelling, and mechanical). Thus, asthma being a chronic disease shows a complex behaviour, resulting from internal memory, 124 and therefore requires a systems approach.
Long-range correlations, functional asthma phenotype, and disease stability
Long-range correlations can provide information about the stability of a complex system. A high value of α (ie, more deterministic) is consistent with a functionally more stable system, whereas a low value (ie, more random) is consistent with a more unstable and unpredictable lung function. However, the mean value of the fl uctuating parameter should be taken into account. Theoretically, a high mean PEF value combined with a high α represents a stable healthy system, whereas a low mean PEF combined with a high α value might be perceived as an airway disease with remodelled airway structure but on a stable regimen and hence with good predictability. Unfortunately, there are no studies (eg, in COPD) to substantiate this scenario (panel, key message 5).
Long-range correlations and bronchodilator responses
We have tested the eff ect of treatment on disease dynamics as measured by α with detrended fl uctuation analysis. 124 Clinical and physiological data from the trial were obtained during three 6-month crossover treatments with regular short-acting β 2 agonist given four times a day, regular long-acting β 2 agonist, and matching placebo. During all three study periods, all patients with mild to moderate allergic asthma were on medium doses of inhaled corticosteroids. The presence and extent of long-range correlations were not aff ected by the long-acting β 2 agonists. However, compared with placebo, the short-acting β 2 agonists signifi cantly changed the nature of correlations in the PEF time series such that the series approached a random process. Since a random process is less predictable, this fi nding has important consequences for the risk prediction of future severe obstructive episodes. Short-acting β 2 agonists are the fi rst-line drug for on-demand relief of bronchial obstruction but when given regularly (with an inevitably long interval at night) they drive the internal regulation of airway tone towards a random process, making the system less stable.
124
Quantifi cation of the risk from PEF fl uctuations
In addition to the long-range correlations, the risk of future exacerbations can be calculated from fl uctuations in PEF. The conditional probability π that a patient will encounter a future obstructive episode (eg, with a 124 show how the conditional probability π varies with the long-range correlation exponent α. The diff erent curves correspond to diff erent values of peak expiratory fl ow (PEF). For example, the 95% predicted PEF curve is obtained by assuming that the present PEF is 95% of its predicted value, and the probability π that PEF is less than 80% of the predicted PEF in the next 14 days is computed for a range of α values. The curves show that the risk of future obstructive events with low PEF is very dependent on α.
predicted PEF less than 80%) is not only a function of today's PEF value but also depends on the long-range correlations of the time series of past PEF values. 124 The risk π is therefore not a traditional risk factor based on population statistics (eg, smoking), and represents the individual risk, varies with time, and is dependent on the history of previous events (PEFs). Figure 5 shows how π varies with the present PEF during regular treatment with short-acting and long-acting bronchodilators. If, for example, PEF is 420 L per min, then the chance that PEF falls below 80% of its mean within 7 days is 68% and 53% during short-acting and long-acting β 2 -agonist treatments, respectively. The 15% improvement results from the stronger correlations as characterised by increased α during the long-acting bronchodilator treatment. Thus, by contrast with long-acting β 2 agonists that reduce this risk, regular short-acting salbutamol increases the risk of future exacerbations (panel, key message 6). Furthermore, with model simulations based on previous work, 124 we calculated how π depends on α for several initial values of PEF (fi gure 5). Both the present PEF value and α are crucial for estimation of the risk of future obstructive episodes. This result shows that the association between π and α drama tically depends on the initial present value of PEF. Indeed, despite a high present PEF, a patient can have a ten-fold increased risk of a future obstructive event if α is low. Thus, π and α together might provide new measures to characterise various asthma phenotypes, describe severity, and predict exacerbations (panel, key message 7).
Implications for the future
In complex diseases such as asthma or COPD, the description of disease severity, progression, and risk assessment is restricted with the unidimensional approach (fi gure 6). One possible way to address the complexity of the disease is with a multidimensional approach that includes a combination of several clinical and physiological parameters (fi gure 6). We have argued that observation of the long-term temporal fl uctuations of clinical and physiological markers and the analysis of their correlation properties can add an additional dimension to improve the assessment of asthma severity, risk, and control, and might be used to design future drug trials. Although fl uctuation analysis has been used to identify critical events in other specialties of medicine, [132] [133] [134] the published work on complex-system analysis in chronic asthma is still sparse. Future studies are needed to prospectively examine whether fl uctuation analysis in comparison with averaged scores of symptoms is better correlated with future asthma control and exacerbation risk. Of particular interest is whether fl uctuations in symp toms are related to fl uctuations in lung function or infl ammatory parameters and to what extent fl uctuations in environmental stimuli or genetic factors aff ect both. We suggest that future multidimensional approaches could even be improved by inclusion of fl uctuation analysis of several parameters (fi gure 6; panel, key message 8). We further speculate that the complexsystems approach described here could be applicable to many other chronic diseases with long-range fl uctuations in functional parameters. Clinical experi ence might be seen as the day-to-day way for the clinician to intuitively deal with complexity in asthma, particularly when considering the temporal history of the disease process, which can be complemented by the proposed quantitative complex system approach (panel, key message 9).
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